ProKidney Corp. Class A Ordinary Shares (PROK) is a publicly traded Healthcare sector company. As of October 2, 2026, PROK trades at $1.70 with a market cap of $346.82M and a P/E ratio of 0.00. PROK moved -0.58% today. Year to date, PROK is -23.32%; over the trailing twelve months it is -34.23%. Its 52-week range spans $0.46 to $7.13. Analyst consensus is neutral with an average price target of $5.75. Rallies surfaces PROK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover PROK: 0 strong buy, 2 buy, 2 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $5.75.
| Metric | Value |
|---|---|
| Price | $1.70 |
| Market Cap | $346.82M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.13 |
| 52-Week Low | $0.46 |
| Volume | 73.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $818.00K |
| Net Income | $-165.75M |
| Gross Margin | 0.00% |
5 analysts cover PROK: 0 strong buy, 2 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.75.